These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8062469)

  • 21. A parathyroid cyst with adenoma on thallium-201/technetium-99m subtraction imaging.
    Joo KG; Baeumler GR
    Clin Nucl Med; 1987 Apr; 12(4):319-21. PubMed ID: 3034465
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Use of SPECT with (99m)Tc-Sestamibi in a patient affected by laryngeal carcinoma and parathyroid adenoma].
    Giordano A; Galli J; Corina L; Samanes Gajate AM; D'Andrea G; Almadori G
    Rev Esp Med Nucl; 2000 Jun; 19(3):211-4. PubMed ID: 11062085
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Localization of ectopic parathyroid adenomas by the technetium-thallium subtraction scan.
    Ott R; Lawrence AM; Jorgensen R; Calandra D; Henkin R; Barbato A; Paloyan E
    Am Surg; 1985 Jun; 51(6):344-8. PubMed ID: 2986503
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The diagnostic utility of dual phase Tc-99m sestamibi parathyroid imaging.
    Klieger P; O'Mara R
    Clin Nucl Med; 1998 Apr; 23(4):208-11. PubMed ID: 9554190
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Concomitant hyperparathyroidism and nonmedullary thyroid cancer, with a review of the literature.
    Leitha T; Staudenherz A
    Clin Nucl Med; 2003 Feb; 28(2):113-7. PubMed ID: 12544127
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Misinterpretation of the upper parathyroid adenoma on thallium-201/technetium-99m subtraction scintigraphy.
    Chan TY; Serpell JW; Chan O; Gaunt JI; Young AE; Nunan TO
    Br J Radiol; 1991 Jan; 64(757):1-4. PubMed ID: 1847837
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A case of hypercalcaemic crisis secondary to coexistence of primary hyperparathyroidism and Graves' disease.
    Baldane S; Ipekci SH; Evcen R; Gedik GK; Guler I; Kebapcilar L
    Endocr Regul; 2016 Oct; 50(4):225-228. PubMed ID: 27941175
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of preoperative localization of adenomas of the parathyroid glands by thallium-technetium subtraction scintigraphy, high-resolution ultrasonography and computed tomography.
    Roses DF; Sudarsky LA; Sanger J; Raghavendra BN; Reede DL; Blum M
    Surg Gynecol Obstet; 1989 Feb; 168(2):99-106. PubMed ID: 2536199
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of technetium Tc 99m sestamibi for detection of a parathyroid adenoma in a dog with primary hyperparathyroidism.
    Matwichuk CL; Taylor SM; Wilkinson AA; Dudzic EM; Matte GG; Outerbridge CA; Schmon CL; Ihle SL
    J Am Vet Med Assoc; 1996 Nov; 209(10):1733-6. PubMed ID: 8921031
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Concurrent nonfunctioning parathyroid carcinoma and parathyroid adenoma.
    Ashkenazi D; Elmalah I; Rakover Y; Luboshitzky R
    Am J Otolaryngol; 2006; 27(3):204-6. PubMed ID: 16647986
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Parathyroid adenomas evaluated by Tl-201/Tc-99m pertechnetate subtraction scintigraphy and high-resolution ultrasonography.
    Winzelberg GG; Hydovitz JD; O'Hara KR; Anderson KM; Turbiner E; Danowski TS; Lippe RD; Melada GA; Harrison AM
    Radiology; 1985 Apr; 155(1):231-5. PubMed ID: 2983373
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of thyroid scanning in hyperthyroidism.
    Fogelman I; Cooke SG; Maisey MN
    Eur J Nucl Med; 1986; 11(10):397-400. PubMed ID: 3009197
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sestamibi parathyroid scanning and preoperative localization studies for patients with recurrent/persistent hyperparathyroidism or significant comorbid conditions: development of an optimal localization strategy.
    Peeler BB; Martin WH; Sandler MP; Goldstein RE
    Am Surg; 1997 Jan; 63(1):37-46. PubMed ID: 8985069
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Localization of enlarged parathyroid glands by thallium-201 and technetium-99m subtraction imaging. Gland mass and parathormone levels in primary hyperparathyroidism.
    Gimlette TM; Taylor WH
    Clin Nucl Med; 1985 Apr; 10(4):235-9. PubMed ID: 2986888
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The role of scintigraphy with dual tracer and potassium perchlorate (99mTcO4 & KClO4/ MIBI) in primary hyperparathyroidism].
    Rubello D; Saladini G; Casara D
    Minerva Endocrinol; 2001 Mar; 26(1):13-21. PubMed ID: 11323563
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Parathyroid adenomas and hyperplasia. Dual radionuclide scintigraphy and bone densitometry studies.
    Gupta SM; Belsky JL; Spencer RP; Frias J; Kotch P; Halpin T; Herrera NE
    Clin Nucl Med; 1985 Apr; 10(4):243-7. PubMed ID: 2986890
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of thallium-201 and technetium-99m subtraction scintigraphy for the localisation of parathyroid adenomas.
    Renaut AJ; Georgiannos SN; Goode AW
    Int Surg; 1996; 81(3):302-3. PubMed ID: 9028996
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute presentation of a giant intrathyroidal parathyroid adenoma: a case report.
    Rutledge S; Harrison M; O'Connell M; O'Dwyer T; Byrne MM
    J Med Case Rep; 2016 Oct; 10(1):286. PubMed ID: 27756436
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Localization of abnormal parathyroid glands using thallium-201.
    MacFarlane SD; Hanelin LG; Taft DA; Ryan JA; Fredlund PN
    Am J Surg; 1984 Jul; 148(1):7-13. PubMed ID: 6742331
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection and localization of parathyroid adenomas in patients with hyperparathyroidism using a single radionuclide imaging procedure with technetium-99m-sestamibi (double-phase study).
    Taillefer R; Boucher Y; Potvin C; Lambert R
    J Nucl Med; 1992 Oct; 33(10):1801-7. PubMed ID: 1328564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.